Eupraxia Pharmaceuticals Inc.

NASDAQ: EPRX
Share price (1/8/25): $3.03
Market cap (1/8/25): $108 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Exempt offering of securities

Registration of securities for employees

Initial registration of new securities for Canadian issuers – amended

Registration of securities on exchange

Initial registration of new securities for Canadian issuers

Ownership Filter

Freedman Joseph S.

News Filter

DiffuSphere™ Technology Demonstrates Targeted Drug Release While Minimizing Systemic Exposure for a Period of More Than Six Months

To Present at American College of Rheumatology Convergence 2024 Annual Meeting

Pharmaceuticals’ CEO Dr. James Helliwell to Participate in Webinar Event, “Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed”, on November 15, 2024

Announces Positive Data From Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Consolidated Financial Statements

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Appointment of agent for service of process and undertaking